Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2024-08-14 Regulatory Filings
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Giải trình chênh lệch lợi nhuận sau thuế 6 tháng đầu năm 2024 so với 6 tháng đầu năm 2023
Regulatory Filings Classification · 78% confidence The document is a letter from Imexpharm to the State Securities Commission and Ho Chi Minh Stock Exchange explaining a >10% fluctuation in its 6-month financial results versus the prior year. It is a mandatory regulatory disclosure (variance explanation), not a full interim report, earnings press release, or other specific filing. Therefore, it falls under General Regulatory Filings (RNS).
2024-08-14 Vietnamese
IMP: Nghị quyết HĐQT về việc triển khai phương án phát hành cổ phiếu để tăng vốn CP từ NVCSH
Share Issue/Capital Change Classification · 87% confidence The document is a full Board of Directors resolution announcing and detailing an implementation plan to issue new shares to increase the company’s charter capital from owner’s equity. It is not an AGM or annual/interim financial report, but a corporate announcement concerning a share issuance and capital change. This corresponds to the “Share Issue/Capital Change” filing category.
2024-08-13 Vietnamese
IMP: Thông báo về việc niêm yết và giao dịch cổ phiếu thay đổi niêm yết
Share Issue/Capital Change Classification · 91% confidence The document is an official stock exchange announcement (Sở Giao dịch Chứng khoán TP.HCM) detailing a change in registered listing due to the issuance of new shares for dividend payment. It specifies the type of securities, ticker, number of shares issued, reason (share issue to pay 2023 dividend), effective date, and trading date. This fits the definition of a Share Issue/Capital Change announcement (Code: SHA).
2024-08-08 Vietnamese
IMP: CBTT Biên bản kiểm phiếu và Nghị quyết ĐHĐCĐ lấy ý kiến bằng văn bản
Share Issue/Capital Change Classification · 85% confidence The document is a formal announcement filed on the State Securities Commission and HOSE portals, disclosing the Resolution of the General Meeting of Shareholders approving a bonus share issuance plan that increases charter capital. It details the share issuance ratio, timing, source of funds, and related corporate actions. This is not merely reporting voting results but is specifically about share issuance/capital change. Therefore it fits the Share Issue/Capital Change category (Code: SHA).
2024-08-08 Vietnamese
IMP: Quyết định thay đổi niêm yết
Share Issue/Capital Change Classification · 91% confidence The document is an official decision issued by the Ho Chi Minh City Stock Exchange approving changes to the listing registration of Imexpharm’s common shares, including details of the number of shares before and after issuance, par value, effective date, and reason (payment of dividends). This constitutes a capital change announcement (new share issuance to pay dividends). It is neither a full financial report nor a regulatory notice unrelated to share issuance. Therefore, it falls under the 'Share Issue/Capital Change' category (SHA).
2024-08-06 Vietnamese
IMP: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 32
Regulatory Filings Classification · 85% confidence The document is a formal disclosure on the Vietnamese State Securities Commission and Ho Chi Minh Stock Exchange portals regarding the company’s updated Enterprise Registration Certificate (32nd change). It does not contain financial statements, performance data, or meeting materials, nor is it announcing dividends, voting results, or management changes. It is a regulatory compliance announcement of corporate registration information. This falls under the fallback category for miscellaneous regulatory filings (RNS).
2024-08-02 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.